Research Article
Galectin-10 Is Released in the Nasal Lavage Fluid of Patients with Aspirin-Sensitive Respiratory Disease
Table 1
Clinical characteristics of the study group.
| | HC | ATA | ASRD |
| Subjects () | 15 | 10 | 15 | AGE (years) | 23 (21–34) | 39 (14–62) | 47 (28–74) | Gender M : F | 8 : 7 | 4 : 6 | 2 : 13 | Atopic (%) | 0 | 30 | 47 | Blood Eosinophiis (/mm3) | | | | IgE (IU/mL) | | | | Lisil-aspirin challenge (+) | 0 | 0 | 15 | Methacholine PC20 (mg/mL) | >32 | | | Mean basal FEV (% predicted) | | | |
|
|
HC: Healthy Controls. ATA: Aspirin-Tolerant Asthmatics. ASRD: Aspirin-Sensitive Respiratory Disease patients. FEV: Forced-expiratory-volume. ASRD versus ATA.
|